文献速递消化道肿瘤与早癌

化学扰动组蛋白乙酰化调控结直肠癌分化

Chemical Perturbations Impacting Histone Acetylation Govern Colorectal Cancer Differentiation.
PubMed 文献 · Gastroenterology · 2025-07-07

本研究通过表观遗传小分子库筛选,发现抑制HDAC1/2催化结构域可促进结直肠癌分化并抑制肿瘤生长。H3K27ac和H3K9ac是关键调控标记,富集于HDAC1/2结合区域及分化基因。破坏H3K27ac可逆转分化表型,DAPK3参与该过程。

要点

  • 抑制HDAC1/2催化结构域促进结直肠癌分化并抑制肿瘤生长
  • H3K27ac和H3K9ac是HDAC1/2抑制诱导分化中的关键组蛋白乙酰化标记
  • 靶向降解P300破坏H3K27ac可逆转HDAC1/2抑制诱导的分化表型

核心结论

  • 组蛋白乙酰化是化学可靶向的调控结直肠癌细胞命运机制,表观遗传重编程可作为治疗策略。

研究设计与样本

  • 使用内源性双报告系统筛选靶向表观遗传调控因子的小分子库,并在小鼠和人类结直肠癌模型中评估先导化合物。

主要发现

  • 抑制HDAC1/2催化结构域促进结直肠癌分化并抑制肿瘤生长。
  • 全基因组分析显示H3K27ac和H3K9ac富集于HDAC1/2结合区域,与开放染色质和上调的分化基因相关。
  • 在患者来源结直肠癌类器官中,靶向降解乙酰转移酶P300破坏H3K27ac,可逆转HDAC1/2抑制诱导的分化表型。
  • 遗传筛选揭示死亡相关蛋白激酶3参与HDAC1/2抑制诱导的H3K27ac介导的结直肠癌分化。

临床怎么用

  • HDAC1/2抑制可作为促进结直肠癌分化的表观遗传治疗策略。
  • H3K27ac可作为评估HDAC1/2抑制疗效的关键调控标记。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Aberrant epigenetic programs that suppress differentiation and enhance plasticity drive colorectal cancer (CRC), yet the molecular determinants underlying these processes remain elusive. We aimed to identify and characterize epigenetic regulators of CRC differentiation, uncovering mechanisms that reprogram cancer cell states. METHODS: A small-molecule library targeting epigenetic regulators was screened using an endogenous dual-reporter system. We evaluated lead compounds in mouse and human CRC models via histopathology, cellular assays, epigenetic studies, mass spectrometry-based histone modification profiling, and single-cell RNA sequencing. Integrative analyses of drug-induced chromatin dynamics, gene expression, target engagement, and histone marks elucidated molecular mechanisms. Focused genetic screens were conducted to identify regulators of histone deacetylase (HDAC)1/2-mediated differentiation. RESULTS: We found that inhibition of the HDAC1/2 catalytic domain promotes CRC differentiation and suppresses tumor growth. Unbiased profiling of histone modifications identified acetylation of lysine 27 on histone H3 protein subunit (H3K27ac) and acetylation of lysine 9 on histone H3 protein subunit (H3K9ac) as critical regulatory marks, with genome-wide analyses demonstrating their enrichment at HDAC1/2-bound regions associated with open chromatin and up-regulated differentiation genes. Disrupting H3K27ac by targeted degradation of acetyltransferase E1A binding protein P300 reversed the differentiation phenotype induced by HDAC1/2 inhibition in a patient-derived CRC organoid. Genetic screens revealed that death-associated protein kinase 3 contributes to H3K27ac-mediated CRC differentiation induced by HDAC1/2 inhibition. CONCLUSIONS: Our findings establish histone acetylation as a chemically targetable mechanism governing CRC cell fate and demonstrate that epigenetic reprogramming can be leveraged as a therapeutic strategy. By identifying HDAC1/2 inhibition as a driver of differentiation and revealing H3K27ac as a key regulatory mark, this study provides a framework for targeting chromatin-modifying enzymes to counteract CRC plasticity and improve treatment outcomes.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Likasitwatanakul P, Li Z, Doan P, et al. Chemical Perturbations Impacting Histone Acetylation Govern Colorectal Cancer Differentiation. Gastroenterology. 2025. PMID: 40633623. doi:10.1053/j.gastro.2025.07.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。